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Abstract
Ovine herpesvirus-2 (OvHV-2) infects most sheep, where it establishes an asymptomatic, latent infection. Infection of
susceptible hosts e.g. cattle and deer results in malignant catarrhal fever, a fatal lymphoproliferative disease characterised
by uncontrolled lymphocyte proliferation and non MHC restricted cytotoxicity. The same cell populations are infected in
both cattle and sheep but only in cattle does virus infection cause dysregulation of cell function leading to disease. The
mechanism by which OvHV-2 induces this uncontrolled proliferation is unknown. A number of herpesviruses have been
shown to encode microRNAs (miRNAs) that have roles in control of both viral and cellular gene expression. We
hypothesised that OvHV-2 encodes miRNAs and that these play a role in pathogenesis. Analysis of massively parallel
sequencing data from an OvHV-2 persistently-infected bovine lymphoid cell line (BJ1035) identified forty-five possible virus-
encoded miRNAs. We previously confirmed the expression of eight OvHV-2 miRNAs by northern hybridization. In this study
we used RT-PCR to confirm the expression of an additional twenty-seven OvHV-2-encoded miRNAs. All thirty-five OvHV-2
miRNAs are expressed from the same virus genome strand and the majority (30) are encoded in an approximately 9 kb
region that contains no predicted virus open reading frames. Future identification of the cellular and virus targets of these
miRNAs will inform our understanding of MCF pathogenesis.
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Introduction
Malignant catarrhal fever (MCF) is a fatal disease of cattle, deer
and pigs caused by one of two related gammaherpesviruses (c-
HV), ovine herpesvirus -2 (OvHV-2) or alcelaphine herpesvirus 1
(AlHV-1). MCF is characterized by sudden onset of fever followed
by lymphadenopathy, leukocytosis, severe congestion, necrosis and
erosion of the oral, conjuctival and nasal mucosæ [1]. The disease
occurs as the result of infection of susceptible hosts by contact with
an asymptomatic carrier species that acts as a virus reservoir.
OvHV-2 is the major cause of sheep associated MCF worldwide
[1]. It infects most sheep, where it establishes a latent but
asymptomatic infection. AlHV-1 is the major cause of MCF in
sub-Saharan Africa where the wildebeest is the asymptomatic
carrier species.
The same cell populations are infected in both cattle and sheep
[2,3] but only in cattle does virus infection cause dysregulation of
cell function leading to uncontrolled proliferation, cytotoxicity and
disease. In both species the infected cells arise from common
lymphoid progenitors [4] but interleukin 2-dependent cell lines
can be cultured only from affected animals. There is currently no
tissue culture system for OvHV-2 and such cell lines are the only
resource for working with the virus. In affected species the infected
cells have been described as large granular lymphocytes (LGLs)
[5]. The immortalized cell lines have a variety of phenotypes; all
express CD2 but vary in their expression of CD4 and CD8 [2,3].
The mechanism by which OvHV-2 induces MCF is unknown;
virus-induced cytopathology is thought not to be involved in lesion
development and it has been proposed that tissue damage arises
from non-antigen specific, MHC unrestricted cytotoxicity of the
LGLs. The key question in understanding OvHV-2 pathogenesis
is; why infection of the same cell type in two closely related species
leads to such different disease outcomes, i.e. lymphoid cell
dysregulation and MCF in cattle versus asymptomatic infection
in sheep.
MicroRNAs (miRNAs) constitute a large family of small, non-
coding RNAs functioning in post-transcriptional regulation of
mRNA in eukaryotes [6–8] as well as in a number of viruses,
particularly in the members of the family Herpesviridae [9–11].
miRNA regulation of expression is by binding of the miRNA seed
sequence (,nucleotides 2–8) to complementary sequences in
target mRNAs and directing these for degradation or translational
silencing; the majority of miRNAs target sequences within the 39
UTR [6]. Herpesvirus-encoded miRNAs have been shown to be
effective regulators of both cellular and virus gene expression and
to influence cell processes including the cell cycle [12–17]. The
pathology of the herpesviruses Epstein Barr virus (EBV) and
Marek’s disease virus (MDV) also involves aberrant lymphocyte
proliferation, and virus-encoded miRNAs play a key role in the
induction of this proliferation. Furthermore, deletion of a single
(MDV) or a small cluster (EBV) of virus-encoded miRNAs
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attenuates these viruses [18–20]. Consequently we hypothesized
that OvHV-2 encodes miRNAs that target host mRNAs and that
these constrain virus pathology in sheep and/or induce MCF
pathology in cattle. Identification and characterization of OvHV-
2-encoded miRNAs is therefore essential to allow this hypothesis
to be addressed.
In a previous study we reported the results of massively parallel
sequencing of small RNAs present in the BJ1035 OvHV-2
immortalized bovine LGL cell line and predicted that the virus
encodes up to forty-five miRNAs [21]. Eight of these were
confirmed by northern hybridization [22]. Here we extend these
studies using two PCR protocols to investigate the expression of
the other predicted OvHV-2 miRNAs.
Methods
Cell culture
BJ1035 cells, an immortalized bovine T cell line from an animal
naturally infected with OvHV-2 [3], was grown in suspension
culture in Iscove’s Modified Dulbecco’s Medium (Invitrogen,
Paisley, UK) supplemented with 10% (v/v) foetal calf serum (Sera
Laboratories International, Haywards Heath, UK), 1% (v/v)
penicillin-streptomycin (Invitrogen), 20 U/ml interleukin 2 (No-
vartis Pharmaceuticals UK, Camberley, UK) and incubated at
37uC, 5% CO2. Bovine lymphoid cells were isolated from fresh
blood and lymphoblasts generated as described previously [23]. All
relevant procedures were approved by the University of
Edinburgh Ethical Review Committee and carried out under an
Animal (Scientific Procedures) Act 1996 project licence.
Reverse Transcription PCR (RT-PCR)
Bovine lymphoblasts and BJ1035 cells were pelleted by
centrifugation and total RNA extracted using Trizol (Invitrogen).
cDNA was generated using the miScript II RT Kit (Qiagen,
Crawley, UK) that uses oligo-dT to prime reverse transcription.
For each predicted miRNA, a specific forward primer spanning
the first 15–16 nucleotides of the miRNA was designed (Table S1)
allowing subsequent sequence confirmation of the identity of the
amplified miRNA RT-PCR was performed using miScript SYBR
green PCR kit (Qiagen), with the supplied universal reverse primer
and the miRNA specific forward primers using the annealing
temperatures shown in Table S1. PCR products were fractionated
by electrophoresis using 3% agarose, purified using the Illustra
GFX PCR DNA and Gel Band Purification Kits (GE Healthcare,
Amersham, UK) and cloned using the TOPO TA Cloning Kit
(Invitrogen). Plasmid DNA was isolated using the Qiaprep Spin
Miniprep Kit (Qiagen), analysed by restriction enzyme digestion
and sequenced (GATC Biotech, London UK).
miRNA specific reverse transcription
Individual miRNA specific primers (Table S2) were used to
prime for reverse transcriptase. Each primer also has a 59
conserved region recognised by a universal reverse primer (59-
GTGCAGGGTCCGAGGT-39) [24]. An initial reaction to form
the hairpin structure of the reverse transcription primer (200 mM)
was carried out using the following conditions: 95uC for 30 min,
72uC for 2 min, 37uC for 2 min then 25uC for 2 min. The
concentration of the reverse transcription primer after annealing
was 50 mM. For the reverse transcription reaction 5 mM reverse
transcription primer was used to prime 100 ng of RNA.
Conditions for the reverse transcription reaction were as follows:
16uC for 30 min, 42uC for 30 min then 85uC for 5 min. PCR was
thenperformed using miRNA specific forward primers (Table S2)
and the following conditions: 5 min at 95uC, 40 cycles of: 30 s at
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95uC, 30 s at 60uC, 60 s at 72uC; then finally 7 min at 72uC. PCR
products were fractionated by electrophoresis using 3% agarose.
Reactions were performed in triplicate. The presence of a product
in the BJ1035 cells but not in the uninfected bovine lymphoblast
cells was taken as proof of OvHV-2 miRNA expression.
Results
Using northern hybridization we have previously demonstrated
the expression of the eight of the 45 predicted miRNAs that were
represented by the highest number of reads in our parallel
sequencing data [22]. RT-PCR using miRNA specific forward
primers and a universal reverse primer for the remaining 37
predicted miRNAs initially identified 22 virus-encoded miRNAs
(Table S1, Table 1).
To investigate if the remaining 15 miRNAs are expressed, an
alternative miRNA specific reverse transcription PCR strategy was
adopted. The expression of a predicted miRNA (ovhv2-miR-73-1)
that was shown to have seed sequence homology but no 39
sequence homology with mammalian miR-216a (Figure 1) was
also analysed by this method. The presence of a product in the
BJ1035 cells but not in the uninfected bovine lymphoblast cells was
taken as proof of OvHV-2 miRNA expression. As the forward
primer ends at the nucleotide adjacent to that from which cDNA is
primed, sequencing of the product would generate only primer
sequence. To confirm that amplification was from miRNA and not
genomic DNA a no RT control was performed and no
amplification was observed with any primer set. Expression of a
further 5 miRNAs, including ovhv2-miR-73-1, was confirmed,
(Figure 2). Figure 3 shows the location and direction of
transcription of the thirty-five validated OvHV-2-encoded miR-
NAs.
Discussion
The number of miRNAs expressed by individual herpesviruses
ranges from 8 to 50 [25] and here we demonstrate that OvHV-2
encodes 35 miRNAs. Using a predictive algorithm Walz et al. [26]
predicted 61 hairpin sites in OvHV-2 that might encode miRNAs;
32 of which we have now confirmed to be expressed (Figure 3,
Table 1), three of our validated miRNAs were not predicted by
Walz et al.. All of the validated miRNAs expressed by OvHV-2 are
transcribed in the same orientation, right to left. By convention
virus-encoded miRNAs are named in relation to the nearest open
reading frame (ORF) transcribed in the same direction as the
miRNA; we have followed this convention in naming the OvHV-
2-encoded miRNAs. Those identified in Levy et al. and discussed
in Riaz et al.[22,27] have been renamed to adhere to this
nomenclature (Table 1). Two miRNAs are encoded at the left
hand end of the genome in the region between the terminal repeat
and the 39 end of ORF Ov2, these have been named ovhv2-miR-
Ov2-1 and ovhv2-miR-Ov2-2 (ovhv2-miR-1 in Levy et al.
2012[22]). The OvHV-2 genome, like that of AlHV-1 and equine
herpesvirus 2 (EHV-2) contains two large regions of the genome
with no predicted open reading frames [28]. The majority (30) of
the identified miRNAs are encoded as two clusters at either end of
the larger of these two regions. One cluster, spanning 4377 bp at
the left end of this region, contains 27 miRNAs; a smaller cluster of
three miRNAs is encoded in a 320 bp region at the right hand end
of this region (Figure 3). These miRNAs have been named ovhv2-
miR-17-1 to -30. Ovhv2-mir-17- 29, -20, -17, -10, -6, -3 and -1
were previously designated ovhv2-miR-2 to -8. One miRNA is
encoded in the non-coding region situated toward the right end of
the genome and is designated ovhv2-miR-73-1. The remaining
miRNAs are encoded within ORFs 24 and 61 and are designated
ovhv2-miR-24-1 and ovhv2-miR-61-1.
ovhv2-miR-73-1 was the only OvHV-2-encoded miRNA to
show seed sequence homology to any other reported miRNA,
miR-216a (Figure 1). This miRNA is broadly conserved in
vertebrates and targets PTEN and YBX1 [29,30] down regulation
of which can lead to increased cell survival, hypertrophy, sclerosis,
and a decreased cellular response to stress [31], all symptoms
observed in MCF. We are currently investigating the cellular genes
targeted by ovhv2-miR-73-1.
Figure 1. Comparison of the sequences of ovhv2-miR-73-1 and
miR-216a. Seed sequences (nt 1-7) are shown in red.
doi:10.1371/journal.pone.0097765.g001
Figure 2. Analysis of OvHV-2-encoded miRNA expression using miRNA specific RT-PCR. A) Expression of five predicted OvHV-2-encoded
miRNAs in BJ1035 cells but not uninfected bovine lymphoblasts was confirmed by miRNA specific RT-PCR. Each assay was carried out in triplicate. M:
50 bp and 100 bp markers B) miRNA specific RT-PCR was carried out along with an no RT (-RT) control.
doi:10.1371/journal.pone.0097765.g002
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AlHV-1 is the causative agent of wildebeest-associated MCF
and the sequence identity between the individual ORFs of OvHV-
2 and AlHV-1 varies from 22–83% ([28]). No significant sequence
similarity was found between the non-coding regions of the two
viruses and Blastn analysis failed to identify miRNAs in the AlHV-
1 genome with sequence homology to any OvHV-2 miRNA. A
lack of conservation of miRNAs between closely-related viruses
has also been observed in different Marek’s disease virus strains
[32].
Herpesviruses are generally host species specific and are
considered to have co-evolved with their natural host [33].
Herpesvirus-encoded miRNAs have been shown to regulate both
virus and host gene expression [12–17] and it is likely that these
miRNAs have also co-evolved with their host targets. The different
disease outcomes seen in sheep (natural, co-evolved host) and
cattle (‘‘foreign’’ host may be the result of different virus:host
interactions. Our hypothesis is that OvHV-2-miRNAs interact
differently with sheep and cattle genes and that these differences
play a role in the differing disease outcomes. It is likely that AlHV-
1 does encode miRNAs, but that they have co-evolved to target
wildebeest (natural host) genes in a similar manner to which
OvHV-2 miRNAs have evolved to target sheep genes.
The identification of the miRNAs encoded by OvHV-2 allows
us to study how these miRNAs affect host and virus gene
expression. We have recently shown that viral genes ORF20 (cell
cycle inhibition), ORF 50 (reactivation) and ORF 73 (latency
maintenance) are targeted by ovhv-miR-17-29; ovhv2-miR-17-10
and ovhv2-miR-17-1 respectively[27]. The identification of host
targets of the 35 OvHV2-miRNAs is not straightforward.
Bioinformatic analysis of potential targets for the OvHV2-
miRNAs in the sheep and cattle genome resulted in the
identification of more than 100,000 possible targets in each
genome, an unrealistic number to investigate. We are current
Figure 3. Location of miRNAs in the OvHV-2 genome. A) The relative positions of the predicted miRNAs in the OvHV-2 genome are shown.
Numbering is from Hart et al.[28]. The genome is represented by a thin line and open reading frames (ORFs) are indicated by blue boxes. Boxes above
the line represent ORFs transcribed left to right; those below the line represent ORFs which are transcribed right to left. Only those ORFs adjacent to
predicted miRNAs are named. Arrows indicate the position of the predicted miRNAs; arrows above the line represent miRNAs transcribed left to right,
those below the line represent miRNAs which are transcribed right to left. Dark blue vertical arrows indicate validated miRNAs. Red arrows indicate
non-validated miRNAs named according to the groups listed in Table 1. Those OvHV-2 ORFs closest to validated miRNAs and after which those
miRNAs are named are shown in darkblue. B) The locations of ovhv2-miR-17-1 to -30 are shown in more detail.
doi:10.1371/journal.pone.0097765.g003
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using experimental approaches to investigate cellular targets of the
OvHV-2-miRNAs.
Supporting Information
Table S1 Sequences of specific forward PCR primers
and related annealing temperatures. The sequence of the
forward primers and annealing temperatures used to analyse
expression of the predicted ovhv2-miRNAs are shown. Those
miRNAs which were successfully validated using approach are
shown in bold. ‘‘Group 1’’ etc. represent predicted miRNAs which
were not shown to be expressed.
(DOCX)
Table S2 Sequence of miRNA specific Reverse tran-
scription primers and specific 59 forward primers. For
each of the miRNAs which were not validated using the miScript
assay, the sequence of the primers used to prime cDNA synthesis,
the specific 59 forward primers and the sequence of the universal
reverse PCR primer are shown. ‘‘Group 1’’ etc. represent
predicted miRNAs which were not shown to be expressed.
(DOCX)
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